The Asia-Pacific Next Generation Sequencing (NGS) Market register at a CAGR of 19.8% & surpass USD 6,039.51 million by 2029. It is analyzed as product, applications, end user.

The Middle East and Africa Next Generation Sequencing (NGS) Market spikes at a CAGR of 12.7% & expand USD 791.18 million by 2029. It is categorized as product, applications, end users.

Europe Food Certification Market to grow at a CAGR 7.2% & value to reach USD 4,442.23 million by 2028. It divides by country, on type, source, life cycle, content, flavours, packaging, origin, category, distribution channel and end user.

North Next Generation Sequencing (NGS) Market, By Product  (Instruments, Consumables and Services), Applications (Diagnostics, Biomarker Discovery, Precision Medicine, Drug Discovery, Agriculture and Animal Research and Others), End User (Pharmaceutical & Biotechnology Companies, Research Centers & Academic and Government Institutes and Hospital & Clinics), Country (U.S., Canada, Mexico) Industry Trends & Forecast to 2029.

The Taurine Market boost up with a CAGR of 5.90% & reach USD 427.02 million by 2029. It is analyzed as type, source and application.

The Vegetable Concentrates Market raise at a CAGR of 4.43% during the forecast period by 2028. It is divided into category, vegetable type, and application.

Peptide Synthesis Market was USD 4.7 billion in 2022, would skyrocket to USD 8.82 billion by 2030, and would grow at an 8.20% CAGR throughout the predicted period.

Global Stem Cell and Progenitor Cell-based Therapeutics Market, By Disease Type (Parkinson Disease, Huntington Disease), Applications (Tissue Engineering, Stem Cells, Gene Therapy, Drug Discovery, Nanotechnology), End- Users (Pharmaceutical and Biotechnology Industries, Hospitals, Research Institutes, Biotechnology Companies, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa)-Industry Trends and Forecast to 2029.

Global Angina Market, By Drug Class (Beta Blockers, Nitrates and Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Others), Types (Stable Angina and Unstable Angina, Variant (Prinzmetal) Angina and Microvascular Angina), End User (Hospitals, Cardiology Centers and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

The Psychedelic Drugs Market is growing with a CAGR of 13.3% in the forecast period & is to reach USD 6,401.95 million by 2029 from USD 2,386.72 million in 2021.